# Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

> **NCT02496767** · PHASE3 · COMPLETED · sponsor: **Cytokinetics** · enrollment: 744 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Tirasemtiv
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT02496767
- **Lead sponsor:** Cytokinetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-03
- **Primary completion:** 2017-03-09
- **Final completion:** 2017-09-27
- **Target enrollment:** 744 (ACTUAL)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496767, "Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02496767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*